R. Hohlfeld and H. Wekerle, Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.14599-14606, 2004.

M. Sospedra and R. Martin, Immunology of multiple sclerosis, Annu. Rev. Immunol, vol.23, pp.683-747, 2005.

A. P. Elong-ngono, M. Salou, B. Bahbouhi, J. Soulillou, S. Brouard et al., Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients, Clin. Immunol, vol.144, issue.2, pp.117-126, 2012.

B. Bahbouhi, S. Pettre, L. Berthelot, A. Garcia, A. Ngono et al., T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T cells in multiple sclerosis, Brain, vol.133, pp.1622-1636, 2010.

L. Berthelot, D. A. Laplaud, S. Pettre, C. Ballet, L. Michel et al., Blood CD8 + T cell responses against myelin determinants in multiple sclerosis and healthy individuals, Eur. J. Immunol, vol.38, issue.7, pp.1889-1899, 2008.

Y. K. Chou, D. N. Bourdette, H. Offner, R. Whitham, R. Y. Wang et al., Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis, J. Neuroimmunol, vol.38, issue.1-2, pp.105-113, 1992.

M. P. Crawford, S. X. Yan, S. B. Ortega, R. S. Mehta, R. E. Hewitt et al., High prevalence of autoreactive, neuroantigenspecific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay, Blood, vol.103, issue.11, pp.4222-4231, 2004.

N. Hellings, M. Baree, C. Verhoeven, M. B. D'hooghe, R. Medaer et al., T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls, J. Neurosci. Res, vol.63, issue.3, pp.290-302, 2001.

J. Hong, Y. C. Zang, S. Li, V. M. Rivera, and J. Z. Zhang, Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes, Eur. J. Immunol, vol.34, issue.3, pp.870-881, 2004.

Z. Jingwu, R. Medaer, G. A. Hashim, Y. Chin, E. Van-den-bergloonen et al., Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity, Ann. Neurol, vol.32, issue.3, pp.330-338, 1992.

R. Martin, D. Jaraquemada, M. Flerlage, J. Richert, J. Whitaker et al., Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals, J. Immunol, vol.145, issue.2, pp.540-548, 1990.

I. R. Moldovan, R. A. Rudick, A. C. Cotleur, S. E. Born, J. C. Lee et al., Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression, J. Neuroimmunol, vol.141, issue.1-2, pp.132-140, 2003.

T. Olsson, J. Sun, J. Hillert, B. Hojeberg, H. P. Ekre et al., Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis, Eur. J. Immunol, vol.22, issue.4, pp.1083-1087, 1992.

T. Olsson, W. W. Zhi, B. Hojeberg, V. Kostulas, Y. P. Jiang et al., Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma, J. Clin. Invest, vol.86, issue.3, pp.981-985, 1990.

K. Ota, M. Matsui, E. L. Milford, G. A. Mackin, H. L. Weiner et al., T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis, Nature, vol.346, issue.6280, pp.183-187, 1990.

M. P. Pender, P. A. Csurhes, J. M. Greer, P. D. Mowat, R. D. Henderson et al., Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects, J. Immunol, vol.165, issue.9, pp.5322-5331, 2000.

M. Pette, K. Fujita, D. Wilkinson, D. M. Altmann, J. Trowsdale et al., Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors, Proc. Natl. Acad. Sci. U. S. A, vol.87, issue.20, pp.7968-7972, 1990.

E. Wallstrom, M. Khademi, M. Andersson, R. Weissert, C. Linington et al., Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15) + multiple sclerosis, Eur. J. Immunol, vol.28, issue.10, pp.3329-3335, 1998.

J. Zhang, S. Markovic-plese, B. Lacet, J. Raus, H. L. Weiner et al., Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis, J. Exp. Med, vol.179, issue.3, pp.973-984, 1994.

J. Zhang, H. L. Weiner, and D. A. Hafler, Autoreactive T cells in multiple sclerosis, Int. Rev. Immunol, vol.9, issue.3, pp.183-201, 1992.

B. Serafini, B. Rosicarelli, R. Magliozzi, E. Stigliano, and F. Aloisi, Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis, Brain Pathol, vol.14, issue.2, pp.164-174, 2004.

R. Magliozzi, O. Howell, A. Vora, B. Serafini, R. Nicholas et al., Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology, Brain, vol.130, pp.1089-1104, 2007.

S. L. Hauser, E. Waubant, D. L. Arnold, T. Vollmer, J. Antel et al., B-cell depletion with rituximab in relapsingremitting multiple sclerosis, N. Engl. J. Med, vol.358, issue.7, pp.676-688, 2008.

L. Kappos, D. Li, P. A. Calabresi, P. O'connor, A. Bar-or et al., Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial, Lancet, vol.378, issue.9805, pp.1779-1787, 2011.

M. Duddy, M. Niino, F. Adatia, S. Hebert, M. Freedman et al., Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis, J. Immunol, vol.178, issue.10, pp.6092-6099, 2007.

C. Mauri and A. Bosma, Immune regulatory function of B cells, Annu. Rev. Immunol, vol.30, pp.221-241, 2012.

S. D. Wolf, B. N. Dittel, F. Hardardottir, and C. A. Janeway, Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice, J. Exp. Med, vol.184, issue.6, pp.2271-2278, 1996.

S. Fillatreau, C. H. Sweenie, M. J. Mcgeachy, D. Gray, and S. M. Anderton, B cells regulate autoimmunity by provision of IL-10, Nat. Immunol, vol.3, issue.10, pp.944-950, 2002.

J. Tian, D. Zekzer, L. Hanssen, Y. Lu, A. Olcott et al., Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice, J. Immunol, vol.167, issue.2, pp.1081-1089, 2001.

M. Hagn, K. Sontheimer, K. Dahlke, S. Brueggemann, C. Kaltenmeier et al., Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help, Immunol. Cell Biol, vol.90, issue.4, pp.457-467, 2012.

M. K. Mann, K. Maresz, L. P. Shriver, Y. Tan, and B. N. Dittel, B cell regulation of CD4 + CD25 + T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis, J. Immunol, vol.178, issue.6, pp.3447-3456, 2007.

E. Mizoguchi, A. Mizoguchi, F. I. Preffer, and A. K. Bhan, Regulatory role of mature B cells in a murine model of inflammatory bowel disease, Int. Immunol, vol.12, issue.5, pp.597-605, 2000.

J. Correale, M. Farez, and G. Razzitte, Helminth infections associated with multiple sclerosis induce regulatory B cells, Ann. Neurol, vol.64, issue.2, pp.187-199, 2008.

S. Knippenberg, E. Peelen, J. Smolders, M. Thewissen, P. Menheere et al., Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission, J. Neuroimmunol, vol.239, issue.1-2, pp.80-86, 2011.

Y. Iwata, T. Matsushita, M. Horikawa, D. J. Dilillo, K. Yanaba et al., Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, vol.117, issue.2, pp.530-541, 2011.

C. H. Polman, S. C. Reingold, G. Edan, M. Filippi, H. P. Hartung et al., Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria, Ann. Neurol, vol.58, issue.6, pp.840-846, 2005.

R. Carsetti, M. M. Rosado, and H. Wardmann, Peripheral development of B cells in mouse and man, Immunol. Rev, vol.197, pp.179-191, 2004.

K. Yanaba, J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto et al., A regulatory B cell subset with a unique CD1dhiCD5 + phenotype controls T cell-dependent inflammatory responses, Immunity, vol.28, issue.5, pp.639-650, 2008.

D. E. Lowther and D. A. Hafler, Regulatory T cells in the central nervous system, Immunol. Rev, vol.248, issue.1, pp.156-169, 2012.

C. Mauri, D. Gray, N. Mushtaq, and M. Londei, Prevention of arthritis by interleukin 10-producing B cells, J. Exp. Med, vol.197, issue.4, pp.489-501, 2003.

J. G. Evans, K. A. Chavez-rueda, A. Eddaoudi, A. Meyer-bahlburg, D. J. Rawlings et al., Novel suppressive function of transitional 2 B cells in experimental arthritis, J. Immunol, vol.178, issue.12, pp.7868-7878, 2007.

T. Matsushita, K. Yanaba, J. D. Bouaziz, M. Fujimoto, and T. F. Tedder, Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression, J. Clin. Invest, vol.118, issue.10, pp.3420-3430, 2008.

A. Bar-or, L. Fawaz, B. Fan, P. J. Darlington, A. Rieger et al., Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?, Ann. Neurol, vol.67, issue.4, pp.452-461, 2010.

M. Niino, M. Hirotani, Y. Miyazaki, and H. Sasaki, Memory and naive B-cell subsets in patients with multiple sclerosis, Neurosci. Lett, vol.464, issue.1, pp.74-78, 2009.

P. A. Blair, L. Y. Norena, F. Flores-borja, D. J. Rawlings, D. A. Isenberg et al., CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients, Immunity, vol.32, issue.1, pp.129-140, 2010.

J. D. Bouaziz, S. Calbo, M. Maho-vaillant, A. Saussine, M. Bagot et al., IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro, Eur. J. Immunol, vol.40, issue.10, pp.2686-2691, 2010.

S. Lemoine, A. Morva, P. Youinou, and C. Jamin, Human T cells induce their own regulation through activation of B cells, J. Autoimmun, vol.36, issue.3-4, pp.228-238, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00771265

M. Niimi, M. Hara, O. Witzke, P. J. Morris, and K. J. Wood, Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: evidence for tolerogenicity of donor resting B cells in vivo, Transplantation, vol.66, issue.12, pp.1786-1792, 1998.

O. Lassila, O. Vainio, and P. Matzinger, Can B cells turn on virgin T cells?, Nature, vol.334, issue.6179, pp.253-255, 1988.

T. Korn, J. Reddy, W. Gao, E. Bettelli, A. Awasthi et al., Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation, Nat. Med, vol.13, issue.4, pp.423-431, 2007.

J. S. Tzartos, M. A. Friese, M. J. Craner, J. Palace, J. Newcombe et al., Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis, Am. J. Pathol, vol.172, issue.1, pp.146-155, 2008.

B. Fritzsching, J. Haas, F. Konig, P. Kunz, E. Fritzsching et al., Intracerebral human regulatory T cells: analysis of CD4 + CD25 + FOXP3 + T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients, PLoS One, vol.6, issue.3, p.17988, 2011.

H. C. Von-budingen, M. D. Harrer, S. Kuenzle, M. Meier, and N. Goebels, Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies, Eur. J. Immunol, vol.38, issue.7, pp.2014-2023, 2008.

D. Lambracht-washington, K. C. O'connor, E. M. Cameron, A. Jowdry, E. S. Ward et al., Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS, J. Neuroimmunol, vol.186, issue.1-2, pp.164-176, 2007.